Mass spectrometric determination of testosterone in multiplexed patient samples

Patent metadata

Field	Value
Publication number	US-11674969-B2
Application number	US-201916355552-A
Country	US
Kind code	B2
Filing date	Mar 15, 2019
Priority date	Mar 16, 2018
Publication date	Jun 13, 2023
Grant date	Jun 13, 2023

Abstract

Provided herein are methods for high throughput quantitation of testosterone utilizing at least two different derivatizing agents of different masses. In another aspect, provided herein are methods for determining the amount of testosterone in each of a plurality of human samples with a single mass spectrometric assay by subjecting each of a plurality of human samples to a different derivatizing agent to generate a differently derivatized testosterone in each of the plurality of samples; combining the plurality of samples to form a multiplex sample; and quantifying the amount of testosterone in each sample by mass spectrometry.

First claim

That which is claimed is:

1. A method for determining the amount of testosterone in each of a plurality of human samples with a single mass spectrometric assay, the method comprising:
i) subjecting each of a plurality of human samples to a different derivatizing agent to generate a differently derivatized testosterone in each of the plurality of samples, wherein the derivatization agents comprise hydroxylamine chloride and methoxylamine chloride;
ii) combining the plurality of samples to form a multiplex sample; and
iii) quantifying the amount of testosterone in each sample by mass spectrometry, wherein the limit of quantitation of the methods is less than or equal to 1 ng/dL.

2. The method of claim 1 , wherein the method further comprises liquid chromatography.

3. The method of claim 2 , wherein said liquid chromatography comprises high performance liquid chromatography (HPLC).

4. The method of claim 2 , wherein said liquid chromatography comprises high turbulence liquid chromatography (HTLC).

5. The method of claim 1 , wherein said ionization comprises heated electrospray ionization (HESI).

6. The method of claim 5 , wherein said ionization is in positive ion mode.

7. The method of claim 1 , wherein the method comprises measuring the amount of one or more precursor ion(s) having a mass-to-charge ratio selected from the group consisting of 304.18±0.5 and 318.21±0.5.

8. The method of claim 1 , wherein the method comprise measuring the amount of one or more fragment ion(s) having a mass-to-charge ratio selected from the group consisting of 112.05±0.5, 124.05±0.5, 126.07±0.5, 138.07±0.5, and 152.08±0.5.

9. The method of claim 1 , further comprising adding an internal standard.

10. The method of claim 9 , wherein said internal standard is isotopically labeled.

11. The method of claim 9 , wherein the method comprises measuring the amount of one or more internal standard precursor ion(s) having a mass-to-charge ratio selected from the group consisting of 307.19±0.5 and 321.21±0.5, or one ore more product ion(s) having a mass-to-charge ratio selected from the group consisting of 127.06±0.5 and 129.07±0.5.

12. The method of claim 1 , wherein the method has a linearity of quantitation across a range between 1 ng/dL to 2,000 ng/dL.

13. The method of claim 1 , wherein the method is fully automated.

14. The method of claim 1 , wherein the method is antibody-free.

15. The method of claim 1 , wherein the sample is serum.

Assignees

• Quest Diagnostics Invest Llc

Inventors

• Goldman Mildred M
• Goldman Scott
• Colletti Julia
• Clarke Nigel

Classifications

• G01N30/50

  Conditioning of the sorbent material or stationary liquid · CPC title

• G01N33/6848

  Methods of protein analysis involving mass spectrometry · CPC title

• G01N33/743 Primary

  Steroid hormones · CPC title